Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes
- 14 June 2013
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 27 (10) , 1981-1987
Abstract
Several groups have published flow cytometry scores useful for the diagnosis or prognosis of myelodysplastic syndromes (MDS), mainly based on the detection of immunophenotypic abnormalities in the maturation of granulocytic/monocytic and lymphoid lineages. As anemia is the most frequent symptom of early MDS, the aim of this study was to identify markers of dyserythropoiesis relevant for the diagnosis of MDS analyzed by selecting erythroblasts in a whole no-lysis bone marrow strategy by using a nuclear dye. This prospective study included 163 patients, including 126 with cytopenias leading to MDS suspicion and 46 controls without MDS. In a learning cohort of 53 unequivocal MDS with specific markers, there was a significant difference between the coefficients of variation of mean fluorescence intensities of CD71 and CD36 in MDS patients compared with controls. These two parameters and the hemoglobin level were used to build a RED-score strongly suggestive of MDS if ⩾3. Using the RED-score in the whole cohort, 80% of MDS or non-MDS patients were correctly classified. When combined with the flow score described by Ogata et al., this strategy allowed to reach a very high sensitivity of 88% of patients correctly classified.Keywords
This publication has 19 references indexed in Scilit:
- Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working GroupLeukemia & Lymphoma, 2012
- Serial assessment of suspected myelodysplastic syndromes: significance of flow cytometric findings validated by cytomorphology, cytogenetics, and molecular geneticsHaematologica, 2012
- Immunophenotypic analysis of erythroid dysplasia and its diagnostic application in myelodysplastic syndromesInternal Medicine Journal, 2012
- Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET studyHaematologica, 2012
- Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: A pilot study on a series of 56 patientsCytometry Part B: Clinical Cytometry, 2010
- Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation studyHaematologica, 2009
- DRAQ5-Based, No-Lyse, No-Wash Bone Marrow Aspirate Evaluation by Flow CytometryAmerican Journal of Clinical Pathology, 2008
- Total nucleated cell differential for blood and bone marrow using a single tube in a five‐color flow cytometerCytometry Part B: Clinical Cytometry, 2007
- Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndromeLeukemia, 2006
- Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndromeLeukemia, 2005